1. Home
  2. CLST vs SCLX Comparison

CLST vs SCLX Comparison

Compare CLST & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLST
  • SCLX
  • Stock Information
  • Founded
  • CLST 1922
  • SCLX 2011
  • Country
  • CLST United States
  • SCLX United States
  • Employees
  • CLST N/A
  • SCLX N/A
  • Industry
  • CLST
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLST
  • SCLX Health Care
  • Exchange
  • CLST Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • CLST 51.0M
  • SCLX 51.3M
  • IPO Year
  • CLST N/A
  • SCLX N/A
  • Fundamental
  • Price
  • CLST $11.74
  • SCLX $4.01
  • Analyst Decision
  • CLST
  • SCLX Strong Buy
  • Analyst Count
  • CLST 0
  • SCLX 4
  • Target Price
  • CLST N/A
  • SCLX $396.67
  • AVG Volume (30 Days)
  • CLST 6.2K
  • SCLX 204.4K
  • Earning Date
  • CLST 04-24-2025
  • SCLX 05-16-2025
  • Dividend Yield
  • CLST N/A
  • SCLX N/A
  • EPS Growth
  • CLST N/A
  • SCLX N/A
  • EPS
  • CLST 0.57
  • SCLX N/A
  • Revenue
  • CLST $11,257,000.00
  • SCLX $56,590,000.00
  • Revenue This Year
  • CLST N/A
  • SCLX $115.30
  • Revenue Next Year
  • CLST N/A
  • SCLX $73.33
  • P/E Ratio
  • CLST $20.69
  • SCLX N/A
  • Revenue Growth
  • CLST 192.24
  • SCLX 21.07
  • 52 Week Low
  • CLST $10.67
  • SCLX $3.60
  • 52 Week High
  • CLST $12.10
  • SCLX $80.50
  • Technical
  • Relative Strength Index (RSI)
  • CLST 58.53
  • SCLX 30.93
  • Support Level
  • CLST $11.52
  • SCLX $4.51
  • Resistance Level
  • CLST $11.79
  • SCLX $6.13
  • Average True Range (ATR)
  • CLST 0.14
  • SCLX 0.82
  • MACD
  • CLST 0.05
  • SCLX 0.10
  • Stochastic Oscillator
  • CLST 92.75
  • SCLX 16.20

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: